Image via Wikipedia
Stem cells found in the amniotic liquid represent new hopes to treat diseases. For the 13th World Congress on Human Reproduction, which is taking place in Venice, Biocell and Toma, two companies based in the Lombardy region active in the field of prenatal diagnosis and biotechnology, today are presenting the results of research conducted by their scientific staff entitled “Characterization and cryoconservation of mesenchymal stem cells from the amniotic liquid”.
“Every day the amniotic liquid reveals its potential as a source of mesenchymal stem cells, creating increasing interest in the field of regenerative medicine,” said Professor Simoni,
Image via Wikipedia
The University of Minnesota is proceeding with embryonic stem cell research, despite an anti-abortion group’s claim that it is illegal under a new ban on the use of state tax dollars for human cloning.
Minnesota Citizens Concerned for Life called on the university Tuesday to “cease its pursuit of human cloning and to end its violation of state law through its ongoing destruction of human embryos.” The organization cited the new cloning ban, along with legislative testimony from a U executive that the ban would stifle “ongoing” research if passed.
University spokeswoman Mary Koppel said the executive’s comments referred
OHSU research demonstrates not all embryonic stem cells are equal; produces the world’s first primate chimeric offspring
Newly published research by scientists at Oregon Health & Science University provides significant new information about how early embryonic stem cells develop and take part in formation of the primate species. The research, which took place at OHSU’s Oregon National Primate Research Center, has also resulted in the first successful birth of chimeric monkeys — monkeys developed from stem cells taken from two separate embryos. The research will be published this week in the online edition of the journal Cell and will be
Image by Beverly & Pack via Flickr
The U.S. government approved the first 13 batches of human embryonic stem cells on Wednesday, enabling researchers using them to get millions of dollars in federal funding as promised by President Barack Obama in March.
“Today we are announcing the approval of the first 13 stem cell lines,” Collins told reporters in a telephone briefing.
In March, Obama lifted restrictions on human embryonic stem cell research imposed by his predecessor, George W. Bush.
He could not lift a restriction set by Congress, called the Dickey-Wicker amendment, that forbids the use of federal money to make the
Adult stem cell research has produced treatments for 73 different conditions, while embryonic stem cell research has not produced a single therapy or helped a single patient. But those facts were conveniently omitted from a recent column advocating increased taxpayer funding of embryonic stem cell research (“Stem cell opportunity,” Commentary, Feb. 20).
The column also neglected to mention the biggest advance in stem cell research in the last decade – the creation of induced pluripotent stem cells.
That development allows researchers to reprogram adult stem cells to behave like embryonic stem cells without destroying human embryos. It was hailed by the